Viatris, Inc. recalls
3 recall notices naming Viatris, Inc. since January 2025, in United States. The most recent was published 28 Oct 2026.
Latest recalls (3)
- Viatris, Inc. recalls Telmisartan and AmlodipineFDASuperpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
- Viatris, Inc. recalls Xanax XRFDAFailed Dissolution Specifications
- Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8 mg and 1 moreFDAFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.